Analysts Are Increasing Price Targets of These 5 Stocks

03. Accolade, Inc. (NASDAQ:ACCD)

Upside Potential: 41%

Accolade, Inc. (NASDAQ:ACCD) was founded in 2007 and is based in Seattle, Washington. It develops and offers personalized, technology-enabled solutions to help individuals navigate and utilize the healthcare system and workplace benefits. Their platform combines cloud-based technology with support from health assistants and clinicians, including registered nurses, physicians, pharmacists, and behavioral health specialists. Additionally, they provide medical opinion, decision support, and administrative services to medical practice PCs offering virtual primary care. Accolade, Inc. (NASDAQ:ACCD) primarily serves employers who want to provide a comprehensive health and benefits solution for their employees and their families. On June 30, Guggenheim increased its price target on Accolade, Inc. (NASDAQ:ACCD) from $18 to $19. This upward revision suggests a positive outlook on the stock’s potential performance. The adjusted price target implies a modest upside for Accolade, Inc. (NASDAQ:ACCD) shares.